Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Appropriators Continue Pressing US FDA To Conduct Surprise In-Person Inspections

Mar 21 2022

• By Derrick Gingery

Related Content

Remote Inspections: Stakeholders Seek Clarity As Some At US FDA Struggle With Process

Feb 23 2022

ARPA-H: New Health Research Agency Faces Old Concerns About Disrupting Private Investment

Feb 09 2022

US FDA Mulls Possibility Of Preannouncing Post-COVID Domestic Surveillance Inspections

Mar 16 2021

Forty-Eight US FDA Drug Application Decisions Delayed By Pandemic's Deferred Inspections

May 05 2021

House Appropriations Committee Embraces Clinical Trial Issues In FY 2022 US FDA Budget Bill

Jul 07 2021

US FDA’s In-Person Foreign Inspections Remain On House Appropriators’ Minds

Jul 07 2021

FDA Would Get Less Funding, Different Inspection Priorities Under Senate Legislation Than House

Aug 05 2021

VMS Market Regulation Gets Targeted Funding In US FDA Budget; OTC Switches Get Question

Mar 16 2022

US FDA Mulls Advance Notice On Domestic Surveillance Inspections Post-COVID

Mar 16 2021

Additional Topics

International United States FDA Legislation Politics Cannabidiol CBD Commercial Compliance Consumer Coronavirus COVID-19 Dietary Supplements Cosmetics Enforcement Ingredients Financing Manufacturing OTC Devices OTC Drugs Policy Regulation

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window